China News Service, September 4, according to the South American Overseas Chinese News Network reported on the 3rd, Fusilo, chairman of the Paraguayan Pulmonology Association, recently stated that every 10 new crowns received treatment at the Paraguayan National Institute of Environmental and Respiratory Diseases (Ineram) and private hospitals Among patients with pneumonia, 8 had taken some medication by themselves before seeking medical attention.
According to reports, during the COVID-19 pandemic, self-medication has become the norm. This phenomenon has aroused great concern among Paraguayan medical staff. They said that people should not abuse drugs without going to the hospital for treatment.
Fucillo said that for every 10 patients with new coronary pneumonia treated at the Paraguay National Institute of Environmental and Respiratory Diseases (Ineram) and private hospitals, 8 have taken ivermectin or hydroxybutyrate on their own for several days before seeing a doctor. Chloroquine, some drugs may have a "placebo effect" on patients, but each patient's condition is different, and prescription drugs must be prescribed by a doctor.
Fucillo also said that although there is usually no specific treatment for viral diseases, certain drugs can relieve symptoms and will not negatively affect the mortality rate. At present, Paraguay mainly uses new coronary pneumonia patients in general wards and intensive care units. Oxygen therapy, anticoagulation therapy and corticosteroid therapy.
Regarding ivermectin, Fucillo pointed out that it is an antiparasitic drug that can prevent the risk of parasitic infection in patients receiving corticosteroid therapy.
In addition, the World Health Organization has warned that antibiotics should not be used as a means to prevent or treat new coronary pneumonia.